ATRA Exercise Disclosure
Redmile Group, Llc · SEC Form 4 · Filed Jul 24, 2026
Exercise
Calculated transaction value
$0
Redmile Group, Llc Director
ATRA
Transaction date
Jul 22, 2026
Public filing date
Jul 25, 2026
Filing lag
Filed 3 days later
ATRA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Pre-Funded Warrants to Purchase Common Stock on Common Stock
- Quantity / price
- 101,089 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-086733
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Atara Biotherapeutics, Inc. ATRA | Exercise | Jul 22, 2026 | $0 |
| Atara Biotherapeutics, Inc. ATRA | Exercise | Jul 22, 2026 | $0 |
| Atara Biotherapeutics, Inc. ATRA | Disposition | Jul 22, 2026 | Not reported |
| Atara Biotherapeutics, Inc. ATRA Current | Exercise | Jul 22, 2026 | $0 |
| Atara Biotherapeutics, Inc. ATRA | Exercise | Jul 22, 2026 | Not reported |